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Summary Three types of natural immune responses against malignant cells were studied in vitro: Cyto-
toxicity mediated by splenic NK cells; cytostasis mediated by splenocytes and binding of naturally occurring
antibodies to various tumour targets. These responses were studied in untreated 3 and 12 month old mice and
in mice of both age groups inoculated with B16 melanoma cells. The results showed that in normal mice NK
activity decreases with age, cytostatic activity remains unchanged and the titre of natural antibodies increases.
Twelve-month old mice were shown to be appreciably more resistant than 3 month old mice to the
development of tumours from subthreshold numbers of B16 tumour cells.
In mice injected with threshold amounts of the B16 tumour, there was no change in any of the responses in
the tumour-free period, but there was a decrease in NK activity and an increase in cytostatic activity when a
large tumour mass developed. An increase in the titre of natural antibodies in young mice injected with the
tumour was also seen. The correlation between these changes and tumour appearance and development is
discussed.
It is well established that aging individuals suffer
from a decline in their natural as well as adaptive
immune functions (Haughton & Whitmore, 1978;
Makinodan & Kay, 1980; Tyan, 1981). The
concurrence of decreased immune reactivity and the
high incidence of tumours in old individuals raises
the possibility that the deterioration of the general
immune status is causally related to the increased
risk of developing spontaneous neoplasms with
advanced age (Keast, 1970).
The decline in immune vigour may be due to
active suppressor mechanisms or to a passive
deterioration of the immune system. Some forms of
immunological decline can be restored by adoptive
transfer into old animals of immunocytes from
young ones (Makinodan & Kay, 1980). In most
cases however, spontaneous tumour development in
old animals was not inhibited or delayed by
administration of immune competent cells from
young donors.
Mediators of natural immunity (NK/NC cells)
(Stutman et al., 1980), macrophages (Keller, 1980)
and natural antibodies (Chow et al., 1981) are often
postulated to function in tumour surveillance by
constituting a first line of defence against the
progression of newly transformed clones.
While certain expressions of natural cellular
immunity such as NK activity decline with aging
(Herberman & Holden, 1978), the titre of naturally
occurring anti tumour antibodies (NATA)
frequently increases with age (Colnaghi et al., 1979;
Witz et al., in press). The decline in NK activity in
mice over the age of 6 months may contribute to
the enhanced growth of certain transplanted
tumours in such mice (Haller et al., 1977).
Enhanced tumour growth can also be brought
about by increased NATA titres (Ehrlich & Witz,
1982).
In a study performed in our laboratory a
population of splenocytes exhibiting cytostasis of
NK-resistant tumour targets was described (Ehrlich
et al., 1981). This immunocyte population, which
may play a role in keeping transformed cells in a
dormant state, appears in mice at a very early age
(10 days) (Ehrlich et al., 1982).
The major goal of this study was to determine
whether any of these 3 natural defence activities
(NK cells, cytostatic cells and NATA) undergoes
alterations in mice during the growth of trans-
planted tumours. In order to meet this goal we
carried out a time course study in which we
followed these three expressions of natural cellular
and humoral activities in 3 month and in 12 month
old mice inoculated with threshold numbers of cells
from the transplanted B16 melanoma. Such a time
course study has allowed us to determine whether
one (or more) of the expressions of natural
immunity changes in tumour-inoculated mice and
whether or not such a change, if it occurs, takes
place before tumours have appeared in animals
destined to develop them.
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Materials and methods
Animals
Three or 12 month old female C57BL/6 mice were
used throughout this study. The mice were
purchased from the Weizmann Institute of Science,
Rehovot, Israel.
Tumours
Cultured B16F1 and B16F10 cells were kindly
supplied by Dr I. Fidler, the Frederick Cancer
Research Centre, Frederick, Md. (Fidler, 1973).
Cultured lines were inoculated s.c. and then
passaged every 15-17 days by s.c. inoculation of
1066cells/mouse. The in vivo grown solid B16
melanoma was kindly supplied by Dr G. Klein,
Dept. Tumour Biology, Karolinska Institute,
Stockholm, Sweden. Tumour passage was
performed as described above. No lung metastases
were seen in mice bearing subcutaneous B16
tumour at the time of harvest.
Target cells for cytostasis were obtained from
solid B16 tumours of similar size (harvested 15-17
days after inoculation) which were cultured as
monolayers for 4-10 passages.
The YAC-1 cell culture (Cikes, 1973) was kindly
given to us by Dr R.B. Herberman and maintained
as a suspension culture in RPMI supplemented with
10% FCS.
Ascites tumours or suspension cultures from the
following ascites tumour cells were also used in this
study: Krebs II, (a gift from Dr G. Klein), is a
tumour of spontaneous origin, in a non-inbred
mouse. The tumour is serially transferred in
BALB/c mice; L5178Y (Fisher & Welch, 1957), is a
lymphoma of spontaneous origin passaged in
syngeneic DBA/2 mice; YAC (Klein & Klein,
1964), is a Moloney virus induced lymphoma
passaged in A/St mice and RL6'1 (Sando et al.,
1975), is a radiation induced lymphoma passaged in
BALB/c mice.
Fixation oftumour cells
Cells were harvested from monolayer cultures using
EDTA-trypsin; from suspension cultures or from 7
day old ascitic tumours (Moav et al., 1982). Five
million cells were suspended and incubated
overnight at 4°C with 1 ml of 0.3% formaldehyde
diluted in PBS with constant shaking. The cells
were then washed 3 times with PBS, resuspended
and stored at a concentration of 5 x 106 cellsml-
in PBS, containing 0.05% sodium azide.
Sera, immunoglobulins and Igfractions
Sera from tumour bearing and from normal mice
were collected by bleeding from the retro-orbital
sinus. A goat anti mouse Fab serum was a gift
from the Dept. Chemical Immunology, Weizmann
Instotute of Science, Rehovot, Israel. The F(ab)2
fraction of this serum (Fab2GaMFab) was
prepared by pepsin digestion of the goat antibodies
followed by an incubation with Staphylococcus
aureus to remove undigested immunoglobulins and
Fc fragments (Nisonoff et al., 1961).
Iodination ofFab2Gc,MFab
lodination with 1251 (Radiochemical Centre,
Amersham, U.K.) was carried out by using the
lodogen method (Fraker & Speck, 1978).
Radioimmunobinding assay
A solid phase radioimmunobinding assay was
performed essentially according to the procedure
described by Huang et al. (1975). Briefly,
50p1 of formalin fixed tumour cell suspension
(5 x 106 cells) in PBS were absorbed to 96-well PVC
u-bottom microtitre plates (Cook Laboratory,
Products Div., Dynatech Laboratories Inc.,
Alexandria, Va.). The plates were air dried.
Unattached sites were saturated with 2% BSA in
PBS. Fifty ,l of diluted sera was added to each well
and incubated for 2h at room temperature. After
thorough washing of the plates 50jul of 12511
Fab2GaMFab (5 x 104- 1 x 105cpm/well) were
added and the plates were incubated overnight at
4°C. The wells were thoroughly washed, dried, cut
and individually counted in an automatic gamma
spectrometer. The binding index (BI) was calculated
according to the following:
BI (test cpm-control cpm) x 100
(reference serum cpm-control cpm)
Test cpm was the 125I Fab2GaxMFab radio-
activity bound to cells preincubated with the
assayed normal serum. Control cpm was the 125I
Fab2GcLMFab radioactivity bound to cells without
preincubation with mouse antibodies. The reference
serum cpm was the 125I Fab2GaxMFab radio-
activity bound to cells preincubated with a reference
antiserum directed against membrane determinants
of the assayed target cells. As reference antiserum
for B16 cells an H-2b antiserum was used. As a
reference antiserum for YAC and L5178Y cells an
anti Thy 1.2 antiserum was used and as reference
for Krebs II cells and H-2b anti H-2d was utilized.
Each serum was tested in duplicate.
NK activity
NK activity mediated by splenocytes was measured
by the 4h or 18h 51Cr release assay using YAC-l
cells as targets. The assay was performed as
described previously (Ehrlich et al., 1980).
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Cytostasis
Cytostatic activity mediated by splenocytes was
determined by the 125IUdR-incorporation-inhibition
assay as described previously (Ehrlich et al., 1981).
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NK activity, cytostasis and NATA in 3 and 12 month
old C57BL/6 mice
Figure 1 shows that there was a significant decline
in NK activity (P<0.05 in Student's t test) in 12
month old mice. However, the NK activity of old
mice could be apparently stimulated during
prolonged incubation periods with the target cells.
Due to this in vitro stimulation, it could be often
seen that when using the 18h 5'Cr release assay the
differences between 3 and 12 month old animals
was not so pronounced.
In contrast to the decline in NK activity the
cytostatic activity did not alter with age (Figure 1).
Figure 2 summarizes the results of a
representative radioimmunobinding assay
measuring the levels of NATA in 3 and 12 month
old normal C57BL/6 mice. The sera from these
mice were assayed for their ability to bind to a
panel composed of several allogeneic tumour cells
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Figure 1 NK activity and cytostasis mediated by
splenocytes from 3 and 12 month old mice. The
ordinate (% activity) represents either NK activity (0;
*) or cytostasis (X). NK activity was measured 51Cr
release in a 4h (0) and in a 18h (0) assay, using
YAC-1 cells as targets. Cytostasis was expressed as %
of inhibition of 1251UDR incorporation into B16-FIO
cells (X). The figure shows the mean result of 4
experiments.
Serum dilution
Figure 2 The binding of sera from normal 3 month old mice (0) and 12 month old mice (0) to RL,31,
YAC-1, KREBS, L5178Y and B16 cells.
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representing "public" target determinants (Witz et
al., 1976; Klein et al., 1979).
Sera from 12 month old mice showed a higher
binding activity to the tumour targets tested,
compared to sera from 3 month old mice. This was
consistent using different serum samples in 6
different binding experiments.
B16 melanoma development in 3 and 12 month old
mice
In the first set of experiments we compared the
growth of B16 tumours in 3 and 12 month old
syngeneic mice, inoculated s.c. with a subthreshold
dose (104cells/mouse) of tumour cells.
Figure 3 shows that B16 tumours grew better in
the 3 month than in the 12 month old mice:
(1) The tumours appeared earlier in the younger
mice (P<0.001 in Logrank test (Peto et al., 1977).
(2) The tumour incidence was significantly higher
in the younger mice (54/54) than in the older mice
(39/54 =61%).
(3) The growth rate of the tumours was faster in
the younger group.
The difference between the growth of these
tumours in 3 and 12 month old mice diminished to
a great extent when a higher dose of tumour cells
(1O cells/mouse) was inoculated (Figure 4).
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Figure 3 The mortality of 3 month and 12 month old
C57BL/6 mice after s.c. inoculation of 104 B16-F1O
melanoma cells in the footpad. The number of
surviving mice is given in the ordinate.
12 month old
Days after tumour inoculation
Figure 4 The mortality of 3 month and 12 month old C57BL/6 mice after s.c. inoculation of 105 B16 (-),
B16-F1 (---) and B16-F1O (--) melanoma cells. The number of surviving mice is given in the ordinate.
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However, even under these circumstances it can be
seen that the younger mice support the growth of
the B16 melanoma (Fidler, 1973) better than the 12
month old animals.
Natural defence in 3 and 12 month old mice
inoculated with B16 cells
In these experiments we compared natural defence
mechanisms in 3 and 12 month old mice developing
B16 tumours or tumours derived from its low (B16-
FI) or high (B16-F10) metastasis variants.
Experimental design
We first determined (Figure 4) than an inoculum of
105 B16-F1 or B16-F1O cells was the minimal
number of cells producing a 100% incidence when
inoculated subcutaneously in 3 or 12 month old
mice.
Groups of 3 or 12 month old mice were then
inoculated s.c. in the footpad (unless otherwise
mentioned) with either 105 B16-Fl or 105 B16-F1O
cells. Several mice from each group were sacrificed
at 7 day intervals following the inoculation. The
serum of these mice was stored frozen for the
subsequent determination of humoral immunity and
the splenocytes were utilized as effectors for NK
and cytostatic activities.
NK and cytostatic activity in C57BL/6 mice
inoculated with high or low B16 metastasis variants
Neither NK nor cytostatic activities changed in
tumour-inoculated mice during the "tumour-free"
latency period which lasted for 5-6 weeks after
tumour inoculation (results not shown). We then
compared the cytostasis and NK activity in 3 and
12 month old tumour-bearers. The following results
were obtained (Table I):
Table I NK and cytostatic activities mediated by splenocytes from
normal mice and from mice bearing B16-F1 and B16-F1O tumours
growing s.c. in the footpad.
NK activity (% 5'Cr-releaseb
(Mean+s.d.c))
Age E:Ta
(months) ratio Normal Control F1 T.B.d FJO T.B.d
3 100:1 38.4+ 7.5(5)e 33.8 + 4.4(5) 31.3+ 4.9(3)e
50:1 28.2+ 4.6 30.6+ 5.2 27.7+ 4.5
25:1 22.2+ 5.8 23.2+ 6.2 19.7+ 4.0
12.5:1 17.4+ 4.8 16.0+ 4.7 16.3+ 4.5
12 100:1 33.7+ 2.3(3)c 34.0+10.5(3)e 18.5+ 5.0(4)e
50:1 27.7+ 2.9 31.0+ 5.3 19.8+ 5.1
25:1 25.7+ 4.0 23.7+ 4.0 20.1+ 5.4
12.5:1 20.3+ 6.4 19.0+ 2.8 17.7+ 5.3
Cytostasis (% 125IUDR
I-I' (Mean+s.d.c))
Age E: Ta
(months) ratio Normal Control F1 T.B.d FJO T.B.d
3 200:1 32.1+12.9(7)e 44.5+16.2(6)e 41.5+ 7.8(2)e
100:1 15.6+12.0 22.5+15.0 27.5+12.0
50:1 6.1+ 8.6 12.2+11.1 14.0+ 9.9
25:1 5.6+ 7.4 6.2+ 9.8 1.5+ 2.1
12 200:1 48.5+11.7(6)e 44.7+18.0(3)c 58.5+ 12.9(4)e
100:1 33.3 + 14.1 23.3 + 11.7 45.5+ 19.1
50:1 12.7+ 14.7 15.3 + 11.7 34.0+15.6
25:1 5.2+ 8.0 6.3+10.8 20.3+11.4
aE:T =Effector:Target.
bThe 18h 5"Cr-release assay was
cells as targets.
Cs.d. =standard deviation.
dT.B. =tumour bearer.
performed on YAC-1 lymphoma
eThe numbers in parentheses indicate the number of tests performed.
Each mouse was tested individually.
'The '25IUDR incorporation-inhibition assay was performed on B16-
FIO melanoma cells as targets.774 R. EHRLICH et al.
(1) Three month old mice bearing B16-Fl or
B16-F10 tumours had cytostatic and NK activities
similar to those of untreated control mice;
(2) Twelve month old mice bearing B16-Fl
tumours also had NK and cytostatic activities
similar to age matched controls;
(3) In contrast to these results 12 month old
mice bearing the high metastasis B16-F1O tumours
had a significant (P<0.05 in Student's t-test)
decrease in their NK activity and a significant
increase in their cytostatic activity. The increase in
cytostasis (with B16-F1O cells as targets) can be
interpreted either as an induced specific adaptive
cellular activity against this syngeneic tumour or as
a general increase in cytostasis.
Significant changes in cytotoxic and cytostatic
activities were seen in 3 month old mice bearing s.c.
B16 tumours or metastasis variants of this tumour
in the abdominal region (Table II). In these mice,
the NK activity markedly decreased and the cyto-
static activity inereased.
NATA in 3 and 12 month old C57BL/6 mice
inoculated with high or low B16 metastasis variants
The sera of 3 or 12 month old mice inoculated with
B16-F1 or with B16-FIO tumours or normal age
matched controls were assayed for their ability to
bind to formalin fixed B16 tumour cells. Tumour-
bearer sera were assayed at various time intervals
after tumour inoculation. The results of 2
experiments represented in Figure 5 show that sera
from 3 month old B16-F1O inoculated but not from
B16-Fl inoculated mice (28 or 35 days after
inoculation of the tumour but still tumour free) had
higher binding activity to B16 cells than sera either
from age matched B16-Fl inoculated mice or non-
inoculated controls. These results were
reproducable as judged from the low standard
deviation ranging from 1-10% of the mean. After
reaching peak titres at 4 or 5 weeks after the
inoculation of the B16-FIO tumour, the titres
decreased as tumours continued to enlarge (45 days
post inoculation).
We did not detect any difference in NATA titres
against seemingly unrelated tumour target cells
between tumour bearers and normal controls in
either of the 2 age groups assayed (results not
shown).
Discussion
Three and 12 month old C57BL/6 mice differ in
their ability to resist the development of tumours
from a subthreshold number of syngeneic
transplantable B16 melanoma cells. Some of the
older mice resisted tumour growth whereas all the
younger ones succumbed to their tumours. A
similar phenomenon was seen when skin cancers
were induced in mice by U.V. irradiation (Ebbessen
& Kripke, 1982) and in mice exposed to certain
chemical carcinogens (Stutman, 1975). In these
cases tumour incidence, size and growth rate were
lower in the older mice. In apparent contrast to
Table II NK and cytostatic activities mediated by splenocytes from normal mice and
mice bearing B16-F1 and B16-F10 tumours growing s.c. in the abdominal region.
NK activity (% 51Cr-releaseb (mean+s.d.0))
Normal Control (3)0 Fl TB.d(3)e Ff0 TB.d(3)e
E: T' Duration ofthe assay
Ratio 4h 18h 4h 18h 4h 18h
100:1 20.4+4.4 61.7+20 14.0+4.6 39.7+ 19.3 18.3+5.5 45.7+ 9.0
50:1 14.0+3.0 47.6+ 8 12.7+6.4 31.1+13.1 10.3+4.9 35.7+ 5.0
25:1 11.7+3.5 31.3+ 5 8.7+4.0 22.3+10.4 8.7+3.1 30.3+ 2.1
12.5:1 11.0+6.1 23.3±+11 6.7+4.7 19.0+ 9.9 4.3±+1.2 20.7+ 8.0
Cytostasis (% 125IUDR I-If (Mean+s.d.c))
Normal Control (2)0 Fl TBd(2)e Ff0 TBd(2)e
200:1 33.5+24.8 72.5+ 13.4 83.5+ 9.2
100:1 15.5+19.1 60.8+ 2.8 72.0+22.6
50:1 4.0+ 5.7 35.5+17.7 47.0+ 4.2
25:1 0+0 11.0+ 8.5 17.5+12.0
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Figure 5 The binding of sera from normal (0), B16-F1 tumour inoculated (A) and B16-F1O tumour
inoculated (A) mice to B16 target cells. Sera from 3 month old mice (top) and sera from 12 month old mice
(bottom) were utilized. Sera were drawn at different time intervals after tumour inoculation. Average values of
2 experiments are given. The reproducibility of the results of these experiments can be evaluated from the
standard deviations given for 28 and 35 post inoculation days.
these results are observations that tumour growth is
enhanced in old animals (Stutman, 1975). For
example, certain transplanted lymphoma lines grow
faster in old mice than in young mice (Haller et al.,
1977). It is therefore clear that no general rules can
be formulated at present as to the effect of aging
on the growth of induced or transplantable
tumours.
It has already been proposed by Talmadge et al.
(1980) that NK activity controls the outgrowth of
inoculated B16 melanomas only if the cells
comprising the inoculum are sensitive to NK-
mediated lysis. The B16 cells utilized in our
laboratory are resistant to lysis mediated by NK
cells (Ehrlich et al., 1981). It is not surprising
therefore, that 12 month old mice, although having
a decreased NK activity (as demonstrated in the
short-term assays), are nonetheless able to resist the
outgrowth of B16 cells at least as efficiently as 3
month old animals. It is thus safe to exclude a role
for NK cells in this particular case, when dealing
with NK-resistant local B16 tumours. On the other
hand, our data do not exclude a role for NK cells
in controlling metastasis formation, even in the B16
system. Indeed such a role has been demonstrated
E
very convincingly (Hanna & Fidler, 1981; Hanna &
Burton, 1981).
The results obtained in this study demonstrate
also that older mice differ from younger ones in
two additional respects: (1) Normal 12 month old
mice have higher titres of NATA than younger
animals against certain tumour targets; (2) Three
month old mice inoculated with highly metastatic
B16-FIO cells (but without palpable tumours) have
anti B16 antibodies while similarly treated 12
month old mice have none. These phenomena could
be responsible for the enhanced growth of B16
tumours in the younger mice. For instance, it is not
unlikely that the increased NATA levels in 12
month old mice retard the proliferation of tumour
cells in these mice. On the other hand, the high
antibody titre to B16 cells in 3 month old B16
bearing mice possibly an adaptive response to
antigens expressed on the tumour (Baniyash et al.,
1982) could facilitate the escape of tumour cells
from destructive effectors and thus enhance tumour
growth (Ehrlich & Witz, 1982).
We could not detect any alteration in any of the
expressions of natural immunity (i.e. NK, cytostasis
and NATA) during the tumour latency period. The
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decreased NK activity observed in some tumour
bearers could thus be a result of the presence of a
large tumour rather than its cause.
This investigation was supported by a grant from the
Concern Foundation in conjunction with the Cohen-
Appelbaum-Feldman Families Cancer Research Fund.
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